Search for: "LILLI JOHNSON"
Results 61 - 80
of 242
Sorted by Relevance
|
Sort by Date
13 Dec 2007, 2:09 am
The antipsychotics include AstraZeneca's Seroquel, Eli Lilly's Zyprexa and Johnson & Johnson's Risperdal and all contain a black box warning on their labeling saying the drugs are associated with an increased risk of death in elderly patients with dementia.Go get ‘em Senator Grassley! [read post]
26 Apr 2007, 2:32 am
The Coalition for Patent Fairness was well-prepared for the introduction of the patent reform bill on April 18, 2007. 3M is a member of the Coalition for 21st Century Patent Reform, which includes some pharma companies (eg, AstraZeneca, Eli Lilly, GlaxoSmithKline, Hoffman-La Roche, Johnson & Johnson, Merck, Millennium Pharmaceuticals).BusinessWeek noted that the Biotechnology Industry Organization [BIO] has expressed opposition to several aspects of the bill.One… [read post]
15 Dec 2016, 11:20 am
Evans predicted that doctors would now favor Jardiance for new patients over other similar drugs called SGLT-2 inhibitors, including Johnson & Johnson's Invokana and AstraZeneca's Farxiga, until they complete their own heart-protection studies in the next two years. [read post]
24 Sep 2008, 3:26 pm
Et tu Johnson & Johnson, Pfizer, Merck, GlaxoSmithKline, or AstraZeneca?? [read post]
20 Aug 2010, 12:56 pm
Johnson & Johnson Jack Tupman, VP Corporate Business Development, Eli Lilly and Company Laura Pierce, Vice President, Alliance Management, Bayer Healthcare Pharmaceuticals Martin Reeves, VP Business Development, Cephalon When: 25-27 October, 2010 Where: The Ritz Carlton, Laguna Nigel, CA Email: bionetwork@wbresearch.com Visit: BioNetwork West *Update!!! [read post]
21 Mar 2017, 8:00 am
The plaintiff, Jo Huskey, and her husband filed a product liability lawsuit against Ethicon Inc. and Johnson & Johnson. [read post]
29 Dec 2009, 9:09 pm
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President,… [read post]
29 Dec 2009, 9:09 pm
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President,… [read post]
25 Jul 2009, 12:32 am
No surprise there.With apologies to Samuel Johnson, the real last refuge of a scoundrel is "differential diagnosis. [read post]
19 Oct 2006, 7:29 pm
The couple sold shares in nine of the companies -- which included Johnson & Johnson, Merck, Boston Scientific, Pfizer, Medtronic and others -- but kept shares in three companies: food and beverage maker PepsiCo; food distributor Sysco; and Kimberly-Clark, which makes some consumer health care products, DOJ said. [read post]
6 Apr 2009, 8:20 am
., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
8 Aug 2008, 5:00 pm
We haven't yet said a peep about the FAS 5 brouhaha.And, Lord knows, we haven't had to.In a nutshell, the Financial Accounting Standards Board has proposed to amend FASB Statement No. 5 to require companies to make additional disclosures about pending "loss contingencies," which means making more public statements about pending litigation.For some of the massive reaction to FASB's proposal, see The Wall Street Journal's editorial on August 7 or the D and O Diary or… [read post]
19 May 2011, 10:24 am
Eli Lilly pleaded guilty to criminal charges for illegally marketing its drug Zyprexa, Pfizer settled a claim that its anti-psychotic drugs were improperly promoted for off label uses, and federal prosecution is pending against Johnson & Johnson for allegedly paying kickbacks to nursing homes to increase Risperdal prescriptions for dementia patients. [read post]
13 Jun 2011, 9:08 am
The three most commonly prescribed atypical antipsychotic drugs are listed in the article as Astra Zeneca's Seroquel, Johnson & Johnson's Risperdal, and Ely Lilly's Zyprexa. [read post]
19 May 2011, 10:24 am
Eli Lilly pleaded guilty to criminal charges for illegally marketing its drug Zyprexa, Pfizer settled a claim that its anti-psychotic drugs were improperly promoted for off label uses, and federal prosecution is pending against Johnson & Johnson for allegedly paying kickbacks to nursing homes to increase Risperdal prescriptions for dementia patients. [read post]
25 Jan 2011, 11:20 am
Many drug companies including Johnson and Johnson, Lilly, Cephalon, Merck, Pfizer, and GlaxoSmithKline have paid more than $257.8 million to doctors since 2009. [read post]
12 May 2011, 2:25 pm
Turns out, federal prosecutors are seeking roughly $1 billion to resolve a long-running probe into Johnson & Johnson’s marketing of the antipsychotic drug Riseprdal. [read post]
19 May 2011, 10:24 am
Eli Lilly pleaded guilty to criminal charges for illegally marketing its drug Zyprexa, Pfizer settled a claim that its anti-psychotic drugs were improperly promoted for off label uses, and federal prosecution is pending against Johnson & Johnson for allegedly paying kickbacks to nursing homes to increase Risperdal prescriptions for dementia patients. [read post]
17 Jan 2007, 5:24 am
.; Eli Lilly, & Co.; GlaxoSmithKline, PLC; Hoffman-LaRoche, Inc.; Johnson & Johnson; Pfizer, Inc.; and Sanofi-Aventis U.S., Inc.Plaintiffs' claim in these cases is that the defendant erroneously classified pharmaceutical sales representatives as exempt from federal or state overtime requirements. [read post]
1 Jul 2010, 1:32 pm
Johnson & Johnson Merck & Co. [read post]
